Please login to the form below
Sitryx
This page shows the latest Sitryx news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Eli Lilly exercises option to progress autoimmune and inflammatory disease therapy
The move triggers an undisclosed milestone payment to Lilly’s partner Sitryx Therapeutics. ... Neil Weir, chief executive officer of Sitryx, said the company was “delighted” that Lilly has chosen to advance SIT-011 within its pipeline.
-
Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs
The five-year deal includes Sitryx’ two lead projects. Sitryx has signed its first big licensing deal with a big pharma company, attracting a $880m-plus partnership with Eli Lilly focusing ... The five-year deal includes Sitryx’ two lead projects,
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
